Pfizer (PFE), BioNTech SE (BNTX) Say Three Vaccine Doses Neutralize Omicron Variant - DJ

December 8, 2021 6:48 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

(Updated - December 8, 2021 6:53 AM EST)

Pfizer (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) said a third dose of their vaccine neutralized Omicron in lab tests, according to Dow Jones.

The two-dose regimen was significantly less effective.

A third dose increased antibodies 25-fold compared to two doses in the variant. Two doses may prove effective in preventing severe illness.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Hot FDA News, Trader Talk